Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

SELL
$96.41 - $126.61 $28,923 - $37,983
-300 Reduced 1.02%
29,110 $3.01 Million
Q2 2023

Aug 16, 2023

SELL
$118.5 - $160.53 $139,237 - $188,622
-1,175 Reduced 3.84%
29,410 $3.57 Million
Q1 2023

May 09, 2023

SELL
$135.66 - $197.02 $250,971 - $364,487
-1,850 Reduced 5.7%
30,585 $4.7 Million
Q4 2022

Feb 03, 2023

SELL
$118.38 - $210.04 $2.09 Million - $3.71 Million
-17,650 Reduced 35.24%
32,435 $5.83 Million
Q3 2022

Oct 14, 2022

SELL
$118.07 - $194.18 $25,385 - $41,748
-215 Reduced 0.43%
50,085 $5.92 Million
Q2 2022

Jul 15, 2022

SELL
$117.13 - $176.59 $26,939 - $40,615
-230 Reduced 0.46%
50,300 $7.19 Million
Q1 2022

Apr 18, 2022

SELL
$126.46 - $235.05 $3 Million - $5.58 Million
-23,750 Reduced 31.97%
50,530 $8.7 Million
Q4 2021

Feb 08, 2022

BUY
$225.82 - $368.51 $1.33 Million - $2.18 Million
5,905 Added 8.64%
74,280 $18.9 Million
Q3 2021

Nov 02, 2021

SELL
$221.9 - $484.47 $11.6 Million - $25.4 Million
-52,425 Reduced 43.4%
68,375 $26.3 Million
Q2 2021

Jul 16, 2021

SELL
$129.91 - $234.98 $3.06 Million - $5.53 Million
-23,550 Reduced 16.31%
120,800 $28.4 Million
Q1 2021

May 03, 2021

BUY
$109.18 - $185.98 $15.8 Million - $26.8 Million
144,350 New
144,350 $18.9 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Heathbridge Capital Management Ltd. Portfolio

Follow Heathbridge Capital Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heathbridge Capital Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Heathbridge Capital Management Ltd. with notifications on news.